CALCOCO1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.481600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.793800E-01
Normal-vs-Stage2
6.576600E-01
Normal-vs-Stage3
1.501610E-03
Normal-vs-Stage4
3.398200E-01
Stage1-vs-Stage2
8.795400E-01
Stage1-vs-Stage3
3.472000E-02
Stage1-vs-Stage4
8.121700E-02
Stage2-vs-Stage3
1.51124999999697E-05
Stage2-vs-Stage4
1.651360E-01
Stage3-vs-Stage4
2.331500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.465600E-01
Normal-vs-AfricanAmerican
4.014600E-01
Normal-vs-Asian
7.508400E-01
Caucasian-vs-AfricanAmerican
7.589800E-01
Caucasian-vs-Asian
9.173400E-01
AfricanAmerican-vs-Asian
7.713200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.843400E-01
Normal-vs-Female
6.060800E-01
Male-vs-Female
7.860600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.890000E-01
Normal-vs-Age(41-60Yrs)
8.677800E-01
Normal-vs-Age(61-80Yrs)
5.957800E-01
Normal-vs-Age(81-100Yrs)
3.237400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.278600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.462400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.291600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.664800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.296980E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.836400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.398200E-01
Normal-vs-Daily Drinker
6.379200E-01
Normal-vs-Weekly Drinker
6.826400E-01
Normal-vs-Occasional Drinker
7.449600E-01
Normal-vs-Social Drinker
9.214000E-01
Non Drinker-vs-Daily Drinker
2.078400E-01
Non Drinker-vs-Weekly Drinker
3.203600E-01
Non Drinker-vs-Occasional Drinker
1.412170E-01
Non Drinker-vs-Social Drinker
1.803420E-01
Daily Drinker-vs-Weekly Drinker
9.714000E-01
Daily Drinker-vs-Occasional Drinker
7.977800E-01
Daily Drinker-vs-Social Drinker
6.073000E-01
Weekly Drinker-vs-Occasional Drinker
8.074200E-01
Weekly Drinker-vs-Social Drinker
6.560000E-01
Occasional Drinker-vs-Social Drinker
7.769600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.248400E-02
Normal-vs-Grade 2
1.305770E-02
Normal-vs-Grade 3
5.423200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.473600E-01
Grade 1-vs-Grade 3
9.144800E-01
Grade 1-vs-Grade 4
4.248400E-02
Grade 2-vs-Grade 3
2.642000E-01
Grade 2-vs-Grade 4
1.305770E-02
Grade 3-vs-Grade 4
5.423200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.025800E-01
Normal-vs-NonDiabetic
5.847600E-01
Diabetic-vs-NonDiabetic
8.576600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.736400E-01
Normal-vs-NoPancreatitis
5.451600E-01
Pancreatitis-vs-NoPancreatitis
4.812000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.294400E-01
Normal-vs-N1
6.337200E-01
N0-vs-N1
9.286200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.516830E-01
Normal-vs-TP53-NonMutant
3.161200E-01
TP53-Mutant-vs-TP53-NonMutant
5.623000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
